Scrip
Bionovo raises cash for Phase III trials of Menerba
06 October 2009
Eleanor Malone
Please Login to read the full article.
06 October 2009
Eleanor Malone
Bionovo has agreed to sell shares and warrants to selected investors to raise up to $20 million.
It will invest the funds in taking its lead drug candidate, Menerba (liquiritigenin), into Phase III trials for postmenopausal vasomotor symptoms. Any proceeds left over will be used for general...
Please Login to read the full article.
RELATED CONTENT
NEWS
- 2009 results preview: big pharma grapples to varying degrees of success with generic erosion
- French industry welcomes moves to boost the biopharmaceutical sector
- Savient to raise $53 million to fund gout treatment approval
- Will combining GSK and Pfizer HIV businesses boost new therapies?
COMMENT
Other Informa Comment
EVENTS
22 March 2010
London, UK
12 April 2010
Orlando, Florida
13 April 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
